Non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog

Abstract Sodium channel inhibitor drugs decrease pathological hyperactivity in various diseases including pain syndromes, myotonia, arrhythmias, nerve injuries and epilepsies. Inhibiting pathological but not physiological activity, however, is a major challenge in drug development. Sodium channel in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Peter Lukacs, Mátyás C. Földi, Luca Valánszki, Emilio Casanova, Beáta Biri-Kovács, László Nyitray, András Málnási-Csizmadia, Arpad Mike
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f48d2435c9aa4403b15cfc5aca00707f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f48d2435c9aa4403b15cfc5aca00707f
record_format dspace
spelling oai:doaj.org-article:f48d2435c9aa4403b15cfc5aca00707f2021-12-02T15:07:44ZNon-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog10.1038/s41598-018-26444-y2045-2322https://doaj.org/article/f48d2435c9aa4403b15cfc5aca00707f2018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-26444-yhttps://doaj.org/toc/2045-2322Abstract Sodium channel inhibitor drugs decrease pathological hyperactivity in various diseases including pain syndromes, myotonia, arrhythmias, nerve injuries and epilepsies. Inhibiting pathological but not physiological activity, however, is a major challenge in drug development. Sodium channel inhibitors exert their effects by a dual action: they obstruct ion flow (“block”), and they alter the energetics of channel opening and closing (“modulation”). Ideal drugs would be modulators without blocking effect, because modulation is inherently activity-dependent, therefore selective for pathological hyperactivity. Can block and modulation be separated? It has been difficult to tell, because the effect of modulation is obscured by conformation-dependent association/dissociation of the drug. To eliminate dynamic association/dissociation, we used a photoreactive riluzole analog which could be covalently bound to the channel; and found, unexpectedly, that drug-bound channels could still conduct ions, although with modulated gating. The finding that non-blocking modulation is possible, may open a novel avenue for drug development because non-blocking modulators could be more specific in treating hyperactivity-linked diseases.Peter LukacsMátyás C. FöldiLuca ValánszkiEmilio CasanovaBeáta Biri-KovácsLászló NyitrayAndrás Málnási-CsizmadiaArpad MikeNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-11 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Peter Lukacs
Mátyás C. Földi
Luca Valánszki
Emilio Casanova
Beáta Biri-Kovács
László Nyitray
András Málnási-Csizmadia
Arpad Mike
Non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog
description Abstract Sodium channel inhibitor drugs decrease pathological hyperactivity in various diseases including pain syndromes, myotonia, arrhythmias, nerve injuries and epilepsies. Inhibiting pathological but not physiological activity, however, is a major challenge in drug development. Sodium channel inhibitors exert their effects by a dual action: they obstruct ion flow (“block”), and they alter the energetics of channel opening and closing (“modulation”). Ideal drugs would be modulators without blocking effect, because modulation is inherently activity-dependent, therefore selective for pathological hyperactivity. Can block and modulation be separated? It has been difficult to tell, because the effect of modulation is obscured by conformation-dependent association/dissociation of the drug. To eliminate dynamic association/dissociation, we used a photoreactive riluzole analog which could be covalently bound to the channel; and found, unexpectedly, that drug-bound channels could still conduct ions, although with modulated gating. The finding that non-blocking modulation is possible, may open a novel avenue for drug development because non-blocking modulators could be more specific in treating hyperactivity-linked diseases.
format article
author Peter Lukacs
Mátyás C. Földi
Luca Valánszki
Emilio Casanova
Beáta Biri-Kovács
László Nyitray
András Málnási-Csizmadia
Arpad Mike
author_facet Peter Lukacs
Mátyás C. Földi
Luca Valánszki
Emilio Casanova
Beáta Biri-Kovács
László Nyitray
András Málnási-Csizmadia
Arpad Mike
author_sort Peter Lukacs
title Non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog
title_short Non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog
title_full Non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog
title_fullStr Non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog
title_full_unstemmed Non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog
title_sort non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/f48d2435c9aa4403b15cfc5aca00707f
work_keys_str_mv AT peterlukacs nonblockingmodulationcontributestosodiumchannelinhibitionbyacovalentlyattachedphotoreactiveriluzoleanalog
AT matyascfoldi nonblockingmodulationcontributestosodiumchannelinhibitionbyacovalentlyattachedphotoreactiveriluzoleanalog
AT lucavalanszki nonblockingmodulationcontributestosodiumchannelinhibitionbyacovalentlyattachedphotoreactiveriluzoleanalog
AT emiliocasanova nonblockingmodulationcontributestosodiumchannelinhibitionbyacovalentlyattachedphotoreactiveriluzoleanalog
AT beatabirikovacs nonblockingmodulationcontributestosodiumchannelinhibitionbyacovalentlyattachedphotoreactiveriluzoleanalog
AT laszlonyitray nonblockingmodulationcontributestosodiumchannelinhibitionbyacovalentlyattachedphotoreactiveriluzoleanalog
AT andrasmalnasicsizmadia nonblockingmodulationcontributestosodiumchannelinhibitionbyacovalentlyattachedphotoreactiveriluzoleanalog
AT arpadmike nonblockingmodulationcontributestosodiumchannelinhibitionbyacovalentlyattachedphotoreactiveriluzoleanalog
_version_ 1718388425511403520